#### ![calendar-Icon](/themes/custom/cosmos/patterns/images/calendar-v2.svg)January 08, 2024

 

 #### San Francisco, USA

 

 

Latest news and interviews for media and investors

 

 

Novartis is attending the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024 in San Francisco, California.



 













 



 

##  Webcast recording 

**Highlights include:**

- Focused strategy
- Robust pipeline
- Attractive growth prospects
- ESG leader

[Download the podcast (MP3 18 MB)](https://prod1.novartis.com/sites/novartis_com/files/2024-01/2024-jpm-novartis-strategy-growth-update.mp3)



 

 [Download the full presentation (PDF 1.3 MB)](/sites/novartis_com/files/2024-jpm-novartis-strategy-growth-update.pdf "Download the full presentation (PDF 1.3 MB)") 



 

 



 





##  Highlights of the presentation 

 [ 

 ![J.P. Morgan 2024, Novartis Strategy and Growth Update slide number 4](/sites/novartis_com/files/styles/cards_1_3/public/2024-01/jpm-2024-novartis-strategy-growth-deck-slide-4.jpg.webp?itok=rvBx-Vs0 "J.P. Morgan 2024, Novartis Strategy and Growth Update slide number 4") 

 

###  Transformation into innovative medicine company 

Explore how our transformation progress has driven performance

 

 

 ](https://www.novartis.com/sites/novartis_com/files/2024-jpm-novartis-strategy-growth-update.pdf#page=4) [ 

 ![J.P. Morgan 2024, Novartis Strategy and Growth Update slide number 7](/sites/novartis_com/files/styles/cards_1_3/public/2024-01/jpm-2024-novartis-strategy-growth-deck-slide-7.jpg.webp?itok=FCiqm4oK "J.P. Morgan 2024, Novartis Strategy and Growth Update slide number 7") 

 

###  Prioritized and enhanced pipeline 

Discover how we deliver high-value medicines across core therapeutic areas through strategic approaches

 

 

 ](https://www.novartis.com/sites/novartis_com/files/2024-jpm-novartis-strategy-growth-update.pdf#page=7) [ 

 ![J.P. Morgan 2024, Novartis Strategy and Growth Update slide number 28](/sites/novartis_com/files/styles/cards_1_3/public/2024-01/jpm-2024-novartis-strategy-growth-deck-slide-28.jpg.webp?itok=VeMfPNOq "J.P. Morgan 2024, Novartis Strategy and Growth Update slide number 28") 

 

###  Continuing to build trust with society 

With focus on material ESG factors that drive value whilst mitigating risks

 

 

 ](https://www.novartis.com/sites/novartis_com/files/2024-jpm-novartis-strategy-growth-update.pdf#page=28) 





 

 [Download the full presentation (PDF 1.3 MB)](/sites/novartis_com/files/2024-jpm-novartis-strategy-growth-update.pdf "Download the full presentation (PDF 1.3 MB)") 

 



## In the news



 



 ![Vasant (Vas) Narasimhan, M.D., Chief Executive Officer (CEO)](/sites/novartis_com/files/styles/cta_image/public/2023-11/vas-narasimhan-1.jpg.webp?itok=PoFX8zUF "Vasant (Vas) Narasimhan, M.D., Chief Executive Officer (CEO)") 

 

##  Novartis CEO Vasant Narasimhan: The right story for the company was to focus on R&D 

CNBC | Jan 9, 2024



 

 [Read more](https://www.cnbc.com/video/2024/01/09/novartis-ceo-vasant-narasimhan-the-right-story-for-the-company-was-to-focus-on-rd.html?&qsearchterm=novartis "Read more") 



 

 



 





### JPM24: Novartis’ head start, FTC fallout and Bluebird’s price defense

Biopharma Dive | Jan 10, 2024

[Read more](https://www.biopharmadive.com/news/jpm-24-biotech-maze-ftc-radiopharmaceuticals-bluebird-price/704210/)



### Novartis dances into JPM with $250M Calypso buyout, $185M RNAi alliance

Fierce Biotech | Jan 8, 2024

[Read more](https://www.fiercebiotech.com/biotech/novartis-dances-jpm-250m-calypso-buyout-185-million-rnai-alliance)



### JPM24: As cancer players jump head-first into ADC field, Novartis CEO explains how he's resisted the temptation

Fierce Biotech | Jan 8, 2024

[Read more](https://www.fiercepharma.com/pharma/jpm24-cancer-players-jump-head-first-adc-field-novartis-ceo-explains-how-hes-resisted)



### Novartis strikes $250M buyout for Merck Serono spinout's autoimmune 'pipeline-in-a-drug'

Endpoints News | Jan 8, 2024

[Read more](https://endpts.com/novartis-to-acquire-calypso-biotech-for-250m-upfront/)









 



###  Partner with Novartis 

Connect with our Corporate & Business Development team and share your opportunities.



 

 [Learn more](/partnering "Learn more") 





 [ 

 ![Mother and daughter cuddling on a bed in a kids room](/sites/novartis_com/files/styles/cards_50_50/public/2023-11/mother-daughter-cuddling-on-a-bed-kid-room-banner.jpg.webp?itok=3GjtnFs5 "Mother and daughter cuddling on a bed in a kids room") 

 

###  Strategy 

Learn about the Novartis strategy and explore our core therapeutic areas and technology platforms.

 

 

 ](/about) [ 

 ![Business woman working on her laptop in a bright atmosphere](/sites/novartis_com/files/styles/cards_50_50/public/2024-10/lp-investors-business-woman-with-a-laptop-on-sofa-banner.jpg.webp?itok=GaTvs6CF "Business woman working on her laptop in a bright atmosphere") 

 

###  Investor Relations 

We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.

 

 

 ](/investors) 





 

 

 



##  Related links 

 

 

 [Pipeline](https://www.novartis.com/research-development/novartis-pipeline "Pipeline") 



 [Leadership](/about/executive-committee "Leadership") 



 

 









---

### Additional resources

J.P. Morgan Healthcare Conference [official website](https://www.jpmorgan.com/about-us/events-conferences/health-care-conference)